{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:56:47Z","timestamp":1794851807948,"version":"4.9.1"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["11E6921N"],"award-info":[{"award-number":["11E6921N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G1179120N"],"award-info":[{"award-number":["G1179120N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1802154N"],"award-info":[{"award-number":["1802154N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Geconcerteerde Onderzoeksactie","award":["FFB180348"],"award-info":[{"award-number":["FFB180348"]}]},{"name":"Geconcerteerde Onderzoeksactie","award":["FFB180348"],"award-info":[{"award-number":["FFB180348"]}]},{"name":"Geconcerteerde Onderzoeksactie","award":["FFB180348"],"award-info":[{"award-number":["FFB180348"]}]},{"name":"Geconcerteerde Onderzoeksactie","award":["FFB180348"],"award-info":[{"award-number":["FFB180348"]}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["TS\/R017581\/1"],"award-info":[{"award-number":["TS\/R017581\/1"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","award":["TS\/R017581\/1"],"award-info":[{"award-number":["TS\/R017581\/1"]}],"id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Methusalem OEC grant - \"GENOMED\"","award":["FFB190208"],"award-info":[{"award-number":["FFB190208"]}]},{"name":"RESOLVE","award":["FP7-305707"],"award-info":[{"award-number":["FP7-305707"]}]},{"name":"RESOLVE","award":["FP7-305707"],"award-info":[{"award-number":["FP7-305707"]}]},{"name":"European Commission projects HEPADIP","award":["LSHM-CT-2005-018734"],"award-info":[{"award-number":["LSHM-CT-2005-018734"]}]},{"name":"European Commission projects HEPADIP","award":["LSHM-CT-2005-018734"],"award-info":[{"award-number":["LSHM-CT-2005-018734"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"DOI":"10.1186\/s13148-025-01945-6","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T18:54:34Z","timestamp":1754333674000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Gradual DNA methylation changes reveal transcription factors implicated in metabolic dysfunction-associated steatotic liver disease progression and epigenetic age acceleration"],"prefix":"10.1186","volume":"17","author":[{"given":"Evelien","family":"Van Dijck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Logie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Fransen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Fallowfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia M.","family":"Mateiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Libert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Van Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Verrijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Van Gaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Francque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Hul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim Vanden","family":"Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"issue":"Suppl","key":"1945_CR1","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Kalligeros M, Henry L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2025;31(Suppl):S32-s50.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"1945_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the study of liver diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"21","key":"1945_CR3","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1056\/NEJMra1503519","volume":"377","author":"AM Diehl","year":"2017","unstructured":"Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063\u201372.","journal-title":"N Engl J Med"},{"issue":"5","key":"1945_CR4","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1002\/hep.24001","volume":"52","author":"H Tilg","year":"2010","unstructured":"Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology. 2010;52(5):1836\u201346.","journal-title":"Hepatology"},{"key":"1945_CR5","doi-asserted-by":"publisher","first-page":"5698931","DOI":"10.1155\/2016\/5698931","volume":"2016","author":"SK Biswas","year":"2016","unstructured":"Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev. 2016;2016:5698931.","journal-title":"Oxid Med Cell Longev"},{"key":"1945_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","volume":"152","author":"Z Chen","year":"2020","unstructured":"Chen Z, Tian R, She Z, Cai J, Li H. Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease. Free Radical Biol Med. 2020;152:116\u201341.","journal-title":"Free Radical Biol Med"},{"issue":"1","key":"1945_CR7","doi-asserted-by":"publisher","first-page":"4234061","DOI":"10.1155\/2016\/4234061","volume":"2016","author":"S Li","year":"2016","unstructured":"Li S, Hong M, Tan H-Y, Wang N, Feng Y. Insights into the role and interdependence of oxidative stress and inflammation in liver diseases. Oxid Med Cell Longev. 2016;2016(1):4234061.","journal-title":"Oxid Med Cell Longev"},{"issue":"5","key":"1945_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3390\/medicina58050641","volume":"58","author":"M Petrescu","year":"2022","unstructured":"Petrescu M, Vlaicu SI, Cium\u0103rnean L, Milaciu MV, M\u0103rginean C, Florea M, et al. Chronic inflammation-a link between nonalcoholic fatty liver disease (NAFLD) and dysfunctional adipose tissue. Medicina. 2022;58(5):641.","journal-title":"Medicina"},{"issue":"6","key":"1945_CR9","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3892\/etm.2021.10034","volume":"21","author":"MM Pomacu","year":"2021","unstructured":"Pomacu MM, Tra\u0219c\u0103 MD, P\u0103dureanu V, Bug\u0103 AM, Andrei AM, St\u0103nciulescu EC, et al. Interrelation of inflammation and oxidative stress in liver cirrhosis. Exp Ther Med. 2021;21(6):602.","journal-title":"Exp Ther Med"},{"issue":"9","key":"1945_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851\u201361.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"1945_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43856-022-00228-y","volume":"3","author":"JM Schattenberg","year":"2023","unstructured":"Schattenberg JM, Allen AM, Jarvis H, Zelber-Sagi S, Cusi K, Dillon JF, et al. A multistakeholder approach to innovations in NAFLD care. Commun Med (Lond). 2023;3(1):1.","journal-title":"Commun Med (Lond)"},{"issue":"10213","key":"1945_CR12","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","volume":"394","author":"SA Harrison","year":"2019","unstructured":"Harrison SA, Bashir MR, Guy CD, Zhou R, Moylan CA, Frias JP, et al. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2019;394(10213):2012\u201324.","journal-title":"Lancet"},{"issue":"6","key":"1945_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390(6):497\u2013509.","journal-title":"N Engl J Med"},{"issue":"1","key":"1945_CR14","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jhep.2009.03.021","volume":"51","author":"IP Pogribny","year":"2009","unstructured":"Pogribny IP, Tryndyak VP, Bagnyukova TV, Melnyk S, Montgomery B, Ross SA, et al. Hepatic epigenetic phenotype predetermines individual susceptibility to hepatic steatosis in mice fed a lipogenic methyl-deficient diet. J Hepatol. 2009;51(1):176\u201386.","journal-title":"J Hepatol"},{"issue":"21","key":"1945_CR15","doi-asserted-by":"publisher","first-page":"8138","DOI":"10.3390\/ijms21218138","volume":"21","author":"J Hyun","year":"2020","unstructured":"Hyun J, Jung Y. DNA methylation in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21(21):8138.","journal-title":"Int J Mol Sci"},{"key":"1945_CR16","doi-asserted-by":"publisher","first-page":"101111","DOI":"10.1016\/j.molmet.2020.101111","volume":"50","author":"W Jonas","year":"2021","unstructured":"Jonas W, Sch\u00fcrmann A. Genetic and epigenetic factors determining NAFLD risk. Mol Metab. 2021;50:101111.","journal-title":"Mol Metab"},{"key":"1945_CR17","doi-asserted-by":"crossref","unstructured":"Vachher M, Bansal S, Kumar B, Yadav S, Burman A. Deciphering the role of aberrant DNA methylation in NAFLD and NASH. Heliyon. 2022;8(10).","DOI":"10.1016\/j.heliyon.2022.e11119"},{"issue":"2","key":"1945_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, Adams LA, Bjornsson ES, Charatcharoenwitthaya P, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389-97.e10.","journal-title":"Gastroenterology"},{"issue":"5","key":"1945_CR19","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology. 2012;56(5):1751\u20139.","journal-title":"Hepatology"},{"issue":"6","key":"1945_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"},{"issue":"1","key":"1945_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/ijms17010097","volume":"17","author":"EM Brunt","year":"2016","unstructured":"Brunt EM. Nonalcoholic fatty liver disease: pros and cons of histologic systems of evaluation. Int J Mol Sci. 2016;17(1):97.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"1945_CR22","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.cgh.2007.06.005","volume":"5","author":"SP Larson","year":"2007","unstructured":"Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA. Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass. Clin Gastroenterol Hepatol. 2007;5(11):1329\u201332.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1945_CR23","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1111\/liv.15571","volume":"43","author":"YY Li","year":"2023","unstructured":"Li YY, Zheng TL, Xiao SY, Wang P, Yang WJ, Jiang LL, et al. Hepatocytic ballooning in non-alcoholic steatohepatitis: dilemmas and future directions. Liver Int. 2023;43(6):1170\u201382.","journal-title":"Liver Int"},{"issue":"4","key":"1945_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/hep.21346","volume":"44","author":"RB Merriman","year":"2006","unstructured":"Merriman RB, Ferrell LD, Patti MG, Weston SR, Pabst MS, Aouizerat BE, et al. Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease. Hepatology. 2006;44(4):874\u201380.","journal-title":"Hepatology"},{"issue":"1","key":"1945_CR25","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12876-020-01400-1","volume":"20","author":"SM Schmitz","year":"2020","unstructured":"Schmitz SM, Kroh A, Ulmer TF, Andruszkow J, Luedde T, Brozat JF, et al. Evaluation of NAFLD and fibrosis in obese patients\u2014a comparison of histological and clinical scoring systems. BMC Gastroenterol. 2020;20(1):254.","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"1945_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cgh.2008.12.015","volume":"7","author":"R Vuppalanchi","year":"2009","unstructured":"Vuppalanchi R, Unalp A, Van Natta ML, Cummings OW, Sandrasegaran KE, Hameed T, et al. Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease. Clin Gastroenterol Hepatol. 2009;7(4):481\u20136.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1945_CR27","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1016\/j.jhep.2022.03.026","volume":"76","author":"QM Anstee","year":"2022","unstructured":"Anstee QM, Castera L, Loomba R. Impact of non-invasive biomarkers on hepatology practice: past, present and future. J Hepatol. 2022;76(6):1362\u201378.","journal-title":"J Hepatol"},{"issue":"1","key":"1945_CR28","doi-asserted-by":"publisher","first-page":"100873","DOI":"10.1016\/j.aohep.2022.100873","volume":"28","author":"D Contreras","year":"2023","unstructured":"Contreras D, Gonz\u00e1lez-Rocha A, Clark P, Barquera S, Denova-Guti\u00e9rrez E. Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: systematic review and meta-analysis. Ann Hepatol. 2023;28(1):100873.","journal-title":"Ann Hepatol"},{"key":"1945_CR29","doi-asserted-by":"publisher","first-page":"154259","DOI":"10.1016\/j.metabol.2020.154259","volume":"111","author":"MT Long","year":"2020","unstructured":"Long MT, Gandhi S, Loomba R. Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Metabolism. 2020;111:154259.","journal-title":"Metabolism"},{"issue":"Suppl","key":"1945_CR30","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.3350\/cmh.2022.0426","volume":"29","author":"TC Yip","year":"2023","unstructured":"Yip TC, Lyu F, Lin H, Li G, Yuen PC, Wong VW, et al. Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future. Clin Mol Hepatol. 2023;29(Suppl):S171\u201383.","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"1945_CR31","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1159\/000235677","volume":"55","author":"J Frith","year":"2009","unstructured":"Frith J, Day CP, Henderson E, Burt AD, Newton JL. Non-alcoholic fatty liver disease in older people. Gerontology. 2009;55(6):607\u201313.","journal-title":"Gerontology"},{"issue":"1","key":"1945_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12876-019-0972-6","volume":"19","author":"P Golabi","year":"2019","unstructured":"Golabi P, Paik J, Reddy R, Bugianesi E, Trimble G, Younossi ZM. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol. 2019;19(1):56.","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"1945_CR33","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.jhep.2010.06.009","volume":"53","author":"M Hoare","year":"2010","unstructured":"Hoare M, Das T, Alexander G. Ageing, telomeres, senescence, and liver injury. J Hepatol. 2010;53(5):950\u201361.","journal-title":"J Hepatol"},{"issue":"6","key":"1945_CR34","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","volume":"57","author":"EM Koehler","year":"2012","unstructured":"Koehler EM, Schouten JNL, Hansen BE, van Rooij FJA, Hofman A, Stricker BH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. J Hepatol. 2012;57(6):1305\u201311.","journal-title":"J Hepatol"},{"issue":"2","key":"1945_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/S0889-8553(05)70195-3","volume":"30","author":"A Regev","year":"2001","unstructured":"Regev A, Schiff ER. Liver disease in the elderly. Gastroenterol Clin North Am. 2001;30(2):547\u201363.","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"1945_CR36","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/hep.28785","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64(5):1577\u201386.","journal-title":"Hepatology"},{"issue":"7764","key":"1945_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41586-019-1365-2","volume":"571","author":"J Campisi","year":"2019","unstructured":"Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. Nature. 2019;571(7764):183\u201392.","journal-title":"Nature"},{"key":"1945_CR38","first-page":"31","volume":"1","author":"F Coperchini","year":"2024","unstructured":"Coperchini F, Greco A, Teliti M, Croce L, Chytiris S, Magri F, Gaetano C, Rotondi M. Inflamm-ageing: how cytokines and nutrition shape the trajectory of ageing. Cytokine Growth Factor Rev. 2024;1:31\u201342.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6809","key":"1945_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/35041687","volume":"408","author":"T Finkel","year":"2000","unstructured":"Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408(6809):239\u201347.","journal-title":"Nature"},{"issue":"1","key":"1945_CR40","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li X, Li C, Zhang W, Wang Y, Qian P, Huang H. Inflammation and aging: signaling pathways and intervention therapies. Signal Transduct Target Ther. 2023;8(1):239.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1945_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0891-5849(03)00184-9","volume":"35","author":"J Sastre","year":"2003","unstructured":"Sastre J, Pallard\u00f3 FV, Vi\u00f1a J. The role of mitochondrial oxidative stress in aging. Free Radic Biol Med. 2003;35(1):1\u20138.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1945_CR42","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s43587-021-00044-4","volume":"1","author":"ML Elliott","year":"2021","unstructured":"Elliott ML, Caspi A, Houts RM, Ambler A, Broadbent JM, Hancox RJ, et al. Disparities in the pace of biological aging among midlife adults of the same chronological age have implications for future frailty risk and policy. Nat Aging. 2021;1(3):295\u2013308.","journal-title":"Nat Aging"},{"issue":"2","key":"1945_CR43","doi-asserted-by":"publisher","first-page":"e13083","DOI":"10.1111\/acel.13083","volume":"19","author":"CSL Tuttle","year":"2020","unstructured":"Tuttle CSL, Waaijer MEC, Slee-Valentijn MS, Stijnen T, Westendorp R, Maier AB. Cellular senescence and chronological age in various human tissues: a systematic review and meta-analysis. Aging Cell. 2020;19(2):e13083.","journal-title":"Aging Cell"},{"issue":"6","key":"1945_CR44","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1007\/s11357-024-01137-9","volume":"46","author":"S Abudahab","year":"2024","unstructured":"Abudahab S, Kronfol MM, Dozmorov MG, Campbell T, Jahr FM, Nguyen J, et al. Genome-wide analysis of hepatic DNA methylation reveals impact of epigenetic aging on xenobiotic metabolism and transport genes in an aged mouse model. Geroscience. 2024;46(6):5967\u201380.","journal-title":"Geroscience"},{"issue":"1","key":"1945_CR45","first-page":"1","volume":"74","author":"MG Bacalini","year":"2018","unstructured":"Bacalini MG, Franceschi C, Gentilini D, Ravaioli F, Zhou X, Remondini D, et al. Molecular aging of human liver: an epigenetic\/transcriptomic signature. J Gerontol Ser A. 2018;74(1):1\u20138.","journal-title":"J Gerontol Ser A"},{"issue":"10","key":"1945_CR46","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.","journal-title":"Genome Biol"},{"issue":"43","key":"1945_CR47","doi-asserted-by":"publisher","first-page":"15538","DOI":"10.1073\/pnas.1412759111","volume":"111","author":"S Horvath","year":"2014","unstructured":"Horvath S, Erhart W, Brosch M, Ammerpohl O, von Sch\u00f6nfels W, Ahrens M, et al. Obesity accelerates epigenetic aging of human liver. Proc Natl Acad Sci USA. 2014;111(43):15538\u201343.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1945_CR48","doi-asserted-by":"publisher","first-page":"e96685","DOI":"10.1172\/jci.insight.96685","volume":"3","author":"R Loomba","year":"2018","unstructured":"Loomba R, Gindin Y, Jiang Z, Lawitz E, Caldwell S, Djedjos CS, et al. DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis. JCI Insight. 2018;3(2):e96685.","journal-title":"JCI Insight"},{"issue":"4","key":"1945_CR49","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s11357-023-00903-5","volume":"46","author":"M Xia","year":"2024","unstructured":"Xia M, Li W, Lin H, Zeng H, Ma S, Wu Q, et al. DNA methylation age acceleration contributes to the development and prediction of non-alcoholic fatty liver disease. Geroscience. 2024;46(4):3525\u201342.","journal-title":"Geroscience"},{"issue":"22","key":"1945_CR50","doi-asserted-by":"publisher","first-page":"13452","DOI":"10.18632\/aging.206184","volume":"16","author":"H Tong","year":"2024","unstructured":"Tong H, Guo X, Jacques M, Luo Q, Eynon N, Teschendorff AE. Cell-type specific epigenetic clocks to quantify biological age at cell-type resolution. Aging (Albany NY). 2024;16(22):13452\u2013504.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"1945_CR51","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s00535-024-02181-0","volume":"60","author":"H Wang","year":"2024","unstructured":"Wang H, Liu Z, Fan H, Guo C, Zhang X, Li Y, Zhao S, Dai L, Zhao M, Zhang T. Association between advanced fibrosis and epigenetic age acceleration among individuals with MASLD. J Gastroenterol. 2024;60(3):306\u201314.","journal-title":"J Gastroenterol"},{"issue":"13","key":"1945_CR52","doi-asserted-by":"publisher","first-page":"e92264","DOI":"10.1172\/jci.insight.92264","volume":"2","author":"P Lefebvre","year":"2017","unstructured":"Lefebvre P, Lalloyer F, Baug\u00e9 E, Pawlak M, Gheeraert C, Dehondt H, et al. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPAR\u03b1-regulated dermatopontin. JCI Insight. 2017;2(13):e92264.","journal-title":"JCI Insight"},{"issue":"1","key":"1945_CR53","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","volume":"63","author":"S Francque","year":"2015","unstructured":"Francque S, Verrijken A, Caron S, Prawitt J, Paumelle R, Derudas B, et al. PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. J Hepatol. 2015;63(1):164\u201373.","journal-title":"J Hepatol"},{"issue":"2","key":"1945_CR54","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","volume":"4","author":"RA Irizarry","year":"2003","unstructured":"Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4(2):249\u201364.","journal-title":"Biostatistics"},{"issue":"1","key":"1945_CR55","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327.","journal-title":"Biostatistics"},{"issue":"16","key":"1945_CR56","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1093\/bioinformatics\/bti525","volume":"21","author":"S Durinck","year":"2005","unstructured":"Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A, et al. BioMart and bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics. 2005;21(16):3439\u201340.","journal-title":"Bioinformatics"},{"issue":"8","key":"1945_CR57","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the integration of genomic datasets with the R\/Bioconductor package biomaRt. Nat Protoc. 2009;4(8):1184\u201391.","journal-title":"Nat Protoc"},{"issue":"3","key":"1945_CR58","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/bioinformatics\/btt684","volume":"30","author":"TJ Morris","year":"2013","unstructured":"Morris TJ, Butcher LM, Feber A, Teschendorff AE, Chakravarthy AR, Wojdacz TK, et al. ChAMP: 450k chip analysis methylation pipeline. Bioinformatics. 2013;30(3):428\u201330.","journal-title":"Bioinformatics"},{"issue":"24","key":"1945_CR59","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y Tian","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, Yang Z, Beck S, Feber A, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982\u20134.","journal-title":"Bioinformatics"},{"issue":"4","key":"1945_CR60","first-page":"e22","volume":"45","author":"W Zhou","year":"2017","unstructured":"Zhou W, Laird PW, Shen H. Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes. Nucleic Acids Res. 2017;45(4):e22.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1945_CR61","doi-asserted-by":"publisher","first-page":"r105","DOI":"10.1186\/gb-2013-14-9-r105","volume":"14","author":"J Nordlund","year":"2013","unstructured":"Nordlund J, B\u00e4cklin CL, Wahlberg P, Busche S, Berglund EC, Eloranta ML, et al. Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol. 2013;14(9):r105.","journal-title":"Genome Biol"},{"issue":"2","key":"1945_CR62","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/bioinformatics\/btv560","volume":"32","author":"B Phipson","year":"2016","unstructured":"Phipson B, Maksimovic J, Oshlack A. missMethyl: an R package for analyzing data from Illumina\u2019s HumanMethylation450 platform. Bioinformatics. 2016;32(2):286\u20138.","journal-title":"Bioinformatics"},{"issue":"D1","key":"1945_CR63","doi-asserted-by":"publisher","first-page":"D571","DOI":"10.1093\/nar\/gkac935","volume":"51","author":"N Zhou","year":"2022","unstructured":"Zhou N, Yuan X, Du Q, Zhang Z, Shi X, Bao J, et al. FerrDb V2: update of the manually curated database of ferroptosis regulators and ferroptosis-disease associations. Nucleic Acids Res. 2022;51(D1):D571\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"1945_CR64","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1002\/imt2.43","volume":"1","author":"Z Gu","year":"2022","unstructured":"Gu Z. Complex heatmap visualization. iMeta. 2022;1(3):e43.","journal-title":"iMeta"},{"issue":"18","key":"1945_CR65","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","volume":"32","author":"Z Gu","year":"2016","unstructured":"Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. 2016;32(18):2847\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"1945_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13059-020-02126-9","volume":"21","author":"AE Teschendorff","year":"2020","unstructured":"Teschendorff AE, Zhu T, Breeze CE, Beck S. EPISCORE: cell type deconvolution of bulk tissue DNA methylomes from single-cell RNA-Seq data. Genome Biol. 2020;21(1):221.","journal-title":"Genome Biol"},{"issue":"3","key":"1945_CR67","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41592-022-01412-7","volume":"19","author":"T Zhu","year":"2022","unstructured":"Zhu T, Liu J, Beck S, Pan S, Capper D, Lechner M, et al. A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution. Nat Methods. 2022;19(3):296\u2013306.","journal-title":"Nat Methods"},{"issue":"1","key":"1945_CR68","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12859-017-1511-5","volume":"18","author":"AE Teschendorff","year":"2017","unstructured":"Teschendorff AE, Breeze CE, Zheng SC, Beck S. A comparison of reference-based algorithms for correcting cell-type heterogeneity in epigenome-wide association studies. BMC Bioinf. 2017;18(1):105.","journal-title":"BMC Bioinf"},{"issue":"4","key":"1945_CR69","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.molcel.2010.05.004","volume":"38","author":"S Heinz","year":"2010","unstructured":"Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010;38(4):576\u201389.","journal-title":"Mol Cell"},{"issue":"11","key":"1945_CR70","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1038\/s41591-023-02602-2","volume":"29","author":"TJ Kendall","year":"2023","unstructured":"Kendall TJ, Jimenez-Ramos M, Turner F, Ramachandran P, Minnier J, McColgan MD, et al. An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease. Nat Med. 2023;29(11):2939\u201353.","journal-title":"Nat Med"},{"issue":"9","key":"1945_CR71","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1093\/nar\/gkac030","volume":"50","author":"TC Silva","year":"2022","unstructured":"Silva TC, Young JI, Martin ER, Chen XS, Wang L. MethReg: estimating the regulatory potential of DNA methylation in gene transcription. Nucleic Acids Res. 2022;50(9):e51.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1945_CR72","doi-asserted-by":"publisher","first-page":"vbac016","DOI":"10.1093\/bioadv\/vbac016","volume":"2","author":"IMP Badia","year":"2022","unstructured":"Badia IMP, V\u00e9lez Santiago J, Braunger J, Geiss C, Dimitrov D, M\u00fcller-Dott S, et al. decoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinform Adv. 2022;2(1):vbac016.","journal-title":"Bioinform Adv"},{"issue":"11","key":"1945_CR73","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498\u2013504.","journal-title":"Genome Res"},{"issue":"D1","key":"1945_CR74","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1945_CR75","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25\u20139.","journal-title":"Nat Genet"},{"issue":"1","key":"1945_CR76","doi-asserted-by":"publisher","first-page":"iyad031","DOI":"10.1093\/genetics\/iyad031","volume":"224","author":"SA Aleksander","year":"2023","unstructured":"Aleksander SA, Balhoff J, Carbon S, Cherry JM, Drabkin HJ, et al. The gene ontology knowledgebase in 2023. Genetics. 2023;224(1):iyad031.","journal-title":"Genetics"},{"issue":"11","key":"1945_CR77","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 2019;28(11):1947\u201351.","journal-title":"Protein Sci"},{"issue":"D1","key":"1945_CR78","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa M, Furumichi M, Sato Y, Matsuura Y, Ishiguro-Watanabe M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 2025;53(D1):D672\u20137.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1945_CR79","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1945_CR80","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12864-019-5761-7","volume":"20","author":"G Mansell","year":"2019","unstructured":"Mansell G, Gorrie-Stone TJ, Bao Y, Kumari M, Schalkwyk LS, Mill J, et al. Guidance for DNA methylation studies: statistical insights from the illumina EPIC array. BMC Genom. 2019;20(1):366.","journal-title":"BMC Genom"},{"issue":"1","key":"1945_CR81","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13148-021-01129-y","volume":"13","author":"ND Johnson","year":"2021","unstructured":"Johnson ND, Wu X, Still CD, Chu X, Petrick AT, Gerhard GS, et al. Differential DNA methylation and changing cell-type proportions as fibrotic stage progresses in NAFLD. Clin Epigenet. 2021;13(1):152.","journal-title":"Clin Epigenet"},{"issue":"4","key":"1945_CR82","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/15592294.2017.1294305","volume":"12","author":"VD de Mello","year":"2017","unstructured":"de Mello VD, Matte A, Perfilyev A, M\u00e4nnist\u00f6 V, R\u00f6nn T, Nilsson E, et al. Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action. Epigenetics. 2017;12(4):287\u201395.","journal-title":"Epigenetics"},{"issue":"1","key":"1945_CR83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13148-018-0525-9","volume":"10","author":"GS Gerhard","year":"2018","unstructured":"Gerhard GS, Malenica I, Llaci L, Chu X, Petrick AT, Still CD, et al. Differentially methylated loci in NAFLD cirrhosis are associated with key signaling pathways. Clin Epigenet. 2018;10(1):93.","journal-title":"Clin Epigenet"},{"issue":"2","key":"1945_CR84","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.cmet.2013.07.004","volume":"18","author":"M Ahrens","year":"2013","unstructured":"Ahrens M, Ammerpohl O, von Sch\u00f6nfels W, Kolarova J, Bens S, Itzel T, et al. DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery. Cell Metab. 2013;18(2):296\u2013302.","journal-title":"Cell Metab"},{"issue":"5","key":"1945_CR85","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2337\/db18-1193","volume":"68","author":"J Ma","year":"2019","unstructured":"Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, et al. A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for nonalcoholic fatty liver disease. Diabetes. 2019;68(5):1073\u201383.","journal-title":"Diabetes"},{"issue":"5","key":"1945_CR86","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/jcb.20012","volume":"91","author":"T Hsu","year":"2004","unstructured":"Hsu T, Trojanowska M, Watson DK. Ets proteins in biological control and cancer. J Cell Biochem. 2004;91(5):896\u2013903.","journal-title":"J Cell Biochem"},{"key":"1945_CR87","doi-asserted-by":"publisher","first-page":"137235","DOI":"10.1016\/j.ijbiomac.2024.137235","volume":"282","author":"B Gadiraju","year":"2024","unstructured":"Gadiraju B, Magisetty J, Kondreddy V. Transcription factor ETV4 plays a critical role in the development of non-alcoholic fatty liver disease. Int J Biol Macromol. 2024;282:137235.","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"1945_CR88","doi-asserted-by":"publisher","first-page":"100724","DOI":"10.1016\/j.jhepr.2023.100724","volume":"5","author":"Y Guo","year":"2023","unstructured":"Guo Y, Miao X, Sun X, Li L, Zhou A, Zhu X, et al. Zinc finger transcription factor Egf1 promotes non-alcoholic fatty liver disease. JHEP Rep. 2023;5(6):100724.","journal-title":"JHEP Rep"},{"issue":"6","key":"1945_CR89","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41419-019-1672-4","volume":"10","author":"D Liu","year":"2019","unstructured":"Liu D, Wang K, Li K, Xu R, Chang X, Zhu Y, et al. Ets-1 deficiency alleviates nonalcoholic steatohepatitis via weakening TGF-\u03b21 signaling-mediated hepatocyte apoptosis. Cell Death Dis. 2019;10(6):458.","journal-title":"Cell Death Dis"},{"issue":"14","key":"1945_CR90","doi-asserted-by":"publisher","first-page":"e120274","DOI":"10.1172\/jci.insight.120274","volume":"3","author":"D Ramnath","year":"2018","unstructured":"Ramnath D, Irvine KM, Lukowski SW, Horsfall LU, Loh Z, Clouston AD, et al. Hepatic expression profiling identifies steatosis-independent and steatosis-driven advanced fibrosis genes. JCI Insight. 2018;3(14):e120274.","journal-title":"JCI Insight"},{"key":"1945_CR91","doi-asserted-by":"publisher","first-page":"1081500","DOI":"10.3389\/fendo.2023.1081500","volume":"14","author":"C Yu","year":"2023","unstructured":"Yu C, Li X, Zhao Y, Hu Y. The role of FOXA family transcription factors in glucolipid metabolism and NAFLD. Front Endocrinol (Lausanne). 2023;14:1081500.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1945_CR92","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.redox.2018.07.026","volume":"19","author":"DC Levings","year":"2018","unstructured":"Levings DC, Wang X, Kohlhase D, Bell DA, Slattery M. A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations. Redox Biol. 2018;19:235\u201349.","journal-title":"Redox Biol"},{"issue":"24","key":"1945_CR93","doi-asserted-by":"publisher","first-page":"12600","DOI":"10.18632\/aging.102590","volume":"11","author":"A Namani","year":"2019","unstructured":"Namani A, Liu K, Wang S, Zhou X, Liao Y, Wang H, et al. Genome-wide global identification of NRF2 binding sites in A549 non-small cell lung cancer cells by ChIP-Seq reveals NRF2 regulation of genes involved in focal adhesion pathways. Aging (Albany NY). 2019;11(24):12600\u201323.","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"1945_CR94","doi-asserted-by":"publisher","first-page":"8428","DOI":"10.1038\/s41467-023-44088-z","volume":"14","author":"J Jin","year":"2023","unstructured":"Jin J, He Y, Guo J, Pan Q, Wei X, Xu C, et al. BACH1 controls hepatic insulin signaling and glucose homeostasis in mice. Nat Commun. 2023;14(1):8428.","journal-title":"Nat Commun"},{"issue":"2","key":"1945_CR95","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3164\/jcbn.09-122GFR","volume":"48","author":"M Inoue","year":"2011","unstructured":"Inoue M, Tazuma S, Kanno K, Hyogo H, Igarashi K, Chayama K. Bach1 gene ablation reduces steatohepatitis in mouse MCD diet model. J Clin Biochem Nutr. 2011;48(2):161\u20136.","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"1945_CR96","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/hep.21614","volume":"45","author":"SM Rahman","year":"2007","unstructured":"Rahman SM, Schroeder-Gloeckler JM, Janssen RC, Jiang H, Qadri I, Maclean KN, et al. CCAAT\/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology. 2007;45(5):1108\u201317.","journal-title":"Hepatology"},{"issue":"1","key":"1945_CR97","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1101\/gad.948702","volume":"16","author":"ED Rosen","year":"2002","unstructured":"Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, et al. C\/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002;16(1):22\u20136.","journal-title":"Genes Dev"},{"issue":"1","key":"1945_CR98","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12864-023-09458-3","volume":"24","author":"Z Song","year":"2023","unstructured":"Song Z, Wang Y, Lin P, Yang K, Jiang X, Dong J, et al. Identification of key modules and driving genes in nonalcoholic fatty liver disease by weighted gene co-expression network analysis. BMC Genomics. 2023;24(1):414.","journal-title":"BMC Genomics"},{"issue":"1","key":"1945_CR99","first-page":"139875","volume":"2012","author":"JA L\u00f3pez-Vel\u00e1zquez","year":"2012","unstructured":"L\u00f3pez-Vel\u00e1zquez JA, Carrillo-C\u00f3rdova LD, Ch\u00e1vez-Tapia NC, Uribe M, M\u00e9ndez-S\u00e1nchez N. Nuclear receptors in nonalcoholic fatty liver disease. J Lipids. 2012;2012(1):139875.","journal-title":"J Lipids"},{"issue":"2","key":"1945_CR100","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.livres.2020.03.001","volume":"4","author":"X Yang","year":"2020","unstructured":"Yang X, Gonzalez FJ, Huang M, Bi H. Nuclear receptors and non-alcoholic fatty liver disease: an update. Liver Res. 2020;4(2):88\u201393.","journal-title":"Liver Res"},{"issue":"1","key":"1945_CR101","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7150\/ijbs.87305","volume":"20","author":"Z Yang","year":"2024","unstructured":"Yang Z, Danzeng A, Liu Q, Zeng C, Xu L, Mo J, et al. The role of nuclear receptors in the pathogenesis and treatment of non-alcoholic fatty liver disease. Int J Biol Sci. 2024;20(1):113\u201326.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"1945_CR102","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3350\/cmh.2024.0229","volume":"30","author":"A Magdy","year":"2024","unstructured":"Magdy A, Kim HJ, Go H, Lee JM, Sohn HA, Haam K, et al. DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease. Clin Mol Hepatol. 2024;30(4):824\u201344.","journal-title":"Clin Mol Hepatol"},{"key":"1945_CR103","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.bbadis.2017.06.017","volume":"1864","author":"K Sato","year":"2018","unstructured":"Sato K, Meng F, Giang T, Glaser S, Alpini G. Mechanisms of cholangiocyte responses to injury. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1262\u20139.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"1945_CR104","doi-asserted-by":"publisher","first-page":"18045","DOI":"10.1038\/s41598-021-96966-5","volume":"11","author":"L Pantano","year":"2021","unstructured":"Pantano L, Agyapong G, Shen Y, Zhuo Z, Fernandez-Albert F, Rust W, et al. Molecular characterization and cell type composition deconvolution of fibrosis in NAFLD. Sci Rep. 2021;11(1):18045.","journal-title":"Sci Rep"},{"key":"1945_CR105","doi-asserted-by":"crossref","unstructured":"Kamzolas I, Koutsandreas T, Barker CG, Vathrakokoili Pournara A, Weston H, Vacca M, et al. Decoding MASLD Progression: A Molecular Trajectory-Based Framework for Modelling Disease Dynamics. bioRxiv. 2025.","DOI":"10.1101\/2025.01.14.632908"},{"key":"1945_CR106","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.csbj.2019.07.021","volume":"17","author":"NJ Hunt","year":"2019","unstructured":"Hunt NJ, Kang SW, Lockwood GP, Le Couteur DG, Cogger VC. Hallmarks of aging in the liver. Comput Struct Biotechnol J. 2019;17:1151\u201361.","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"1945_CR107","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.jhep.2020.06.025","volume":"73","author":"BA Davison","year":"2020","unstructured":"Davison BA, Harrison SA, Cotter G, Alkhouri N, Sanyal A, Edwards C, et al. Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials. J Hepatol. 2020;73(6):1322\u201332.","journal-title":"J Hepatol"},{"issue":"6","key":"1945_CR108","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/jgh.15843","volume":"37","author":"HH Leung","year":"2022","unstructured":"Leung HH, Puspanathan P, Chan AW, Nik Mustapha NR, Wong VW, Chan WK. Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems. J Gastroenterol Hepatol. 2022;37(6):1131\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"1945_CR109","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s43587-024-00652-w","volume":"4","author":"K Du","year":"2024","unstructured":"Du K, Wang L, Jun JH, Dutta RK, Maeso-D\u00edaz R, Oh SH, et al. Aging promotes metabolic dysfunction-associated steatotic liver disease by inducing ferroptotic stress. Nat Aging. 2024;4(7):949\u201368.","journal-title":"Nat Aging"},{"issue":"8","key":"1945_CR110","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41574-022-00675-6","volume":"18","author":"E Barreby","year":"2022","unstructured":"Barreby E, Chen P, Aouadi M. Macrophage functional diversity in NAFLD\u2014more than inflammation. Nat Rev Endocrinol. 2022;18(8):461\u201372.","journal-title":"Nat Rev Endocrinol"},{"key":"1945_CR111","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.addr.2018.09.006","volume":"135","author":"NJ Hunt","year":"2018","unstructured":"Hunt NJ, McCourt PAG, Le Couteur DG, Cogger VC. Novel targets for delaying aging: the importance of the liver and advances in drug delivery. Adv Drug Deliv Rev. 2018;135:39\u201349.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1945_CR112","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2217\/epi-2016-0087","volume":"9","author":"M Bysani","year":"2017","unstructured":"Bysani M, Perfilyev A, de Mello VD, R\u00f6nn T, Nilsson E, Pihlajam\u00e4ki J, et al. Epigenetic alterations in blood mirror age-associated DNA methylation and gene expression changes in human liver. Epigenomics. 2017;9(2):105\u201322.","journal-title":"Epigenomics"},{"issue":"6","key":"1945_CR113","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/j.cell.2013.02.014","volume":"152","author":"TI Lee","year":"2013","unstructured":"Lee TI, Young RA. Transcriptional regulation and its misregulation in disease. Cell. 2013;152(6):1237\u201351.","journal-title":"Cell"},{"key":"1945_CR114","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-genom-091416-035537","volume":"18","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Ahituv N. Gene regulatory elements, major drivers of human disease. Annu Rev Genom Hum Genet. 2017;18:45\u201363.","journal-title":"Annu Rev Genom Hum Genet"},{"issue":"4","key":"1945_CR115","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert SA, Jolma A, Campitelli LF, Das PK, Yin Y, Albu M, et al. The human transcription factors. Cell. 2018;172(4):650\u201365.","journal-title":"Cell"},{"issue":"5865","key":"1945_CR116","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/297365a0","volume":"297","author":"JE Darnell Jr","year":"1982","unstructured":"Darnell JE Jr. Variety in the level of gene control in eukaryotic cells. Nature. 1982;297(5865):365\u201371.","journal-title":"Nature"},{"issue":"9","key":"1945_CR117","first-page":"4350","volume":"11","author":"DP McDonnell","year":"1991","unstructured":"McDonnell DP, Nawaz Z, O\u2019Malley BW. In situ distinction between steroid receptor binding and transactivation at a target gene. Mol Cell Biol. 1991;11(9):4350\u20135.","journal-title":"Mol Cell Biol"},{"issue":"22","key":"1945_CR118","doi-asserted-by":"publisher","first-page":"10563","DOI":"10.1073\/pnas.89.22.10563","volume":"89","author":"DP McDonnell","year":"1992","unstructured":"McDonnell DP, Vegeto E, O\u2019Malley BW. Identification of a negative regulatory function for steroid receptors. Proc Natl Acad Sci. 1992;89(22):10563\u20137.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"1945_CR119","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13059-024-03218-6","volume":"25","author":"M Rimoldi","year":"2024","unstructured":"Rimoldi M, Wang N, Zhang J, Villar D, Odom DT, Taipale J, et al. DNA methylation patterns of transcription factor binding regions characterize their functional and evolutionary contexts. Genome Biol. 2024;25(1):146.","journal-title":"Genome Biol"},{"issue":"6","key":"1945_CR120","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1042\/EBC20190033","volume":"63","author":"\u00c9 H\u00e9berl\u00e9","year":"2019","unstructured":"H\u00e9berl\u00e9 \u00c9, Bardet AF. Sensitivity of transcription factors to DNA methylation. Essays Biochem. 2019;63(6):727\u201341.","journal-title":"Essays Biochem"},{"issue":"7","key":"1945_CR121","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3390\/metabo10070283","volume":"10","author":"S Steensels","year":"2020","unstructured":"Steensels S, Qiao J, Ersoy BA. Transcriptional regulation in non-alcoholic fatty liver disease. Metabolites. 2020;10(7):283.","journal-title":"Metabolites"},{"issue":"1\u20132","key":"1945_CR122","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0378-1119(01)00771-5","volume":"280","author":"HS Ro","year":"2001","unstructured":"Ro HS, Kim SW, Wu D, Webber C, Nicholson TE. Gene structure and expression of the mouse adipocyte enhancer-binding protein. Gene. 2001;280(1\u20132):123\u201333.","journal-title":"Gene"},{"issue":"6552","key":"1945_CR123","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/378092a0","volume":"378","author":"GP He","year":"1995","unstructured":"He GP, Muise A, Li AW, Ro HS. A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature. 1995;378(6552):92\u20136.","journal-title":"Nature"},{"issue":"13","key":"1945_CR124","doi-asserted-by":"publisher","first-page":"10199","DOI":"10.1074\/jbc.M010640200","volume":"276","author":"SW Kim","year":"2001","unstructured":"Kim SW, Muise AM, Lyons PJ, Ro HS. Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation. J Biol Chem. 2001;276(13):10199\u2013206.","journal-title":"J Biol Chem"},{"issue":"14","key":"1945_CR125","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1093\/emboj\/18.14.4004","volume":"18","author":"JG Park","year":"1999","unstructured":"Park JG, Muise A, He GP, Kim SW, Ro HS. Transcriptional regulation by the gamma5 subunit of a heterotrimeric G protein during adipogenesis. Embo J. 1999;18(14):4004\u201312.","journal-title":"Embo J"},{"issue":"7","key":"1945_CR126","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1073\/pnas.0508139103","volume":"103","author":"A Majdalawieh","year":"2006","unstructured":"Majdalawieh A, Zhang L, Fuki IV, Rader DJ, Ro HS. Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation. Proc Natl Acad Sci USA. 2006;103(7):2346\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"1945_CR127","doi-asserted-by":"publisher","first-page":"e0219764","DOI":"10.1371\/journal.pone.0219764","volume":"14","author":"GS Gerhard","year":"2019","unstructured":"Gerhard GS, Hanson A, Wilhelmsen D, Piras IS, Still CD, Chu X, et al. AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p. PLoS ONE. 2019;14(7):e0219764.","journal-title":"PLoS ONE"},{"issue":"1","key":"1945_CR128","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000456061","volume":"41","author":"Y Lou","year":"2017","unstructured":"Lou Y, Chen YD, Sun FR, Shi JP, Song Y, Yang J. Potential regulators driving the transition in nonalcoholic fatty liver disease: a stage-based view. Cell Physiol Biochem. 2017;41(1):239\u201351.","journal-title":"Cell Physiol Biochem"},{"key":"1945_CR129","first-page":"193","volume-title":"Hepatobiliary Cancers: An Interdisciplinary Approach","author":"DL Vallejo-Ardila","year":"2023","unstructured":"Vallejo-Ardila DL, De Bastiani MA, Salazar DA. Regulators of Genetic Risk for the Progression of Non-alcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Reconstruction of Transcriptional Network and Signature-Based Metabolic Profiling. In: Rezaei N, editor. Hepatobiliary Cancers: An Interdisciplinary Approach. Cham: Springer Nature Switzerland; 2023. p. 193\u2013227."},{"issue":"2","key":"1945_CR130","first-page":"731","volume":"25","author":"XH Liu","year":"2021","unstructured":"Liu XH, Liu LP, Xu XM, Hua M, Kang Q, Li A, et al. FOXN2 suppresses the proliferation and invasion of human hepatocellular carcinoma cells. Eur Rev Med Pharmacol Sci. 2021;25(2):731\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1945_CR131","doi-asserted-by":"publisher","first-page":"101119","DOI":"10.1016\/j.molmet.2020.101119","volume":"50","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Kim M, Lazar MA. Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease. Mol Metab. 2021;50:101119.","journal-title":"Mol Metab"},{"issue":"5","key":"1945_CR132","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.3390\/ijms23052668","volume":"23","author":"T Puengel","year":"2022","unstructured":"Puengel T, Liu H, Guillot A, Heymann F, Tacke F, Peiseler M. Nuclear receptors linking metabolism, inflammation, and fibrosis in nonalcoholic fatty liver disease. Int J Mol Sci. 2022;23(5):2668.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1945_CR133","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1042\/EBC20210020","volume":"65","author":"DE Frigo","year":"2021","unstructured":"Frigo DE, Bondesson M, Williams C. Nuclear receptors: from molecular mechanisms to therapeutics. Essays Biochem. 2021;65(6):847\u201356.","journal-title":"Essays Biochem"},{"issue":"3","key":"1945_CR134","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/metabo12030238","volume":"12","author":"RD Welch","year":"2022","unstructured":"Welch RD, Billon C, Losby M, Bedia-Diaz G, Fang Y, Avdagic A, et al. Emerging role of nuclear receptors for the treatment of NAFLD and NASH. Metabolites. 2022;12(3):238.","journal-title":"Metabolites"},{"issue":"1","key":"1945_CR135","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.livres.2024.03.002","volume":"8","author":"RA Sinha","year":"2024","unstructured":"Sinha RA. Targeting nuclear receptors for NASH\/MASH: from bench to bedside. Liver Res. 2024;8(1):34\u201345.","journal-title":"Liver Res"},{"issue":"3","key":"1945_CR136","doi-asserted-by":"publisher","first-page":"R253","DOI":"10.1152\/ajpregu.00316.2021","volume":"322","author":"J Habibi","year":"2022","unstructured":"Habibi J, Chen D, Hulse JL, Whaley-Connell A, Sowers JR, Jia G. Targeting mineralocorticoid receptors in diet-induced hepatic steatosis and insulin resistance. Am J Physiol Regul Integr Comp Physiol. 2022;322(3):R253\u201362.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"9","key":"1945_CR137","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1089\/thy.2018.0664","volume":"29","author":"RA Sinha","year":"2019","unstructured":"Sinha RA, Bruinstroop E, Singh BK, Yen PM. Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists. Thyroid. 2019;29(9):1173\u201391.","journal-title":"Thyroid"},{"issue":"12","key":"1945_CR138","doi-asserted-by":"publisher","first-page":"e0189223","DOI":"10.1371\/journal.pone.0189223","volume":"12","author":"C Baciu","year":"2017","unstructured":"Baciu C, Pasini E, Angeli M, Schwenger K, Afrin J, Humar A, et al. Systematic integrative analysis of gene expression identifies HNF4A as the central gene in pathogenesis of non-alcoholic steatohepatitis. PLoS ONE. 2017;12(12):e0189223.","journal-title":"PLoS ONE"},{"issue":"10","key":"1945_CR139","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1097\/CM9.0000000000002092","volume":"135","author":"X Pan","year":"2022","unstructured":"Pan X, Zhang Y. Hepatocyte nuclear factor 4\u03b1 in the pathogenesis of non-alcoholic fatty liver disease. Chin Med J (Engl). 2022;135(10):1172\u201381.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"1945_CR140","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13679-024-00556-1","volume":"13","author":"SA Polyzos","year":"2024","unstructured":"Polyzos SA, Targher G. Role of glucocorticoids in metabolic dysfunction-associated steatotic liver disease. Curr Obes Rep. 2024;13(2):242\u201355.","journal-title":"Curr Obes Rep"},{"key":"1945_CR141","doi-asserted-by":"publisher","first-page":"106786","DOI":"10.1016\/j.phrs.2023.106786","volume":"192","author":"Y-Y Qiu","year":"2023","unstructured":"Qiu Y-Y, Zhang J, Zeng F-Y, Zhu YZ. Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). Pharmacol Res. 2023;192:106786.","journal-title":"Pharmacol Res"},{"issue":"6","key":"1945_CR142","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1002\/hep.31604","volume":"73","author":"Y Xu","year":"2021","unstructured":"Xu Y, Zhu Y, Hu S, Xu Y, Stroup D, Pan X, et al. Hepatocyte nuclear factor 4\u03b1 prevents the steatosis-to-NASH progression by regulating p53 and bile acid signaling (in mice). Hepatology. 2021;73(6):2251\u201365.","journal-title":"Hepatology"},{"issue":"12","key":"1945_CR143","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.3390\/biomedicines10123041","volume":"10","author":"C Theys","year":"2022","unstructured":"Theys C, Lauwers D, Perez-Novo C, Vanden BW. PPAR\u03b1 in the epigenetic driver seat of NAFLD: new therapeutic opportunities for epigenetic drugs? Biomedicines. 2022;10(12):3041.","journal-title":"Biomedicines"},{"issue":"17","key":"1945_CR144","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","volume":"385","author":"SM Francque","year":"2021","unstructured":"Francque SM, Bedossa P, Ratziu V, Anstee QM, Bugianesi E, Sanyal AJ, et al. A randomized, controlled trial of the Pan-PPAR agonist lanifibranor in NASH. N Engl J Med. 2021;385(17):1547\u201358.","journal-title":"N Engl J Med"},{"issue":"3","key":"1945_CR145","doi-asserted-by":"publisher","first-page":"433","DOI":"10.21037\/hbsn-21-579","volume":"11","author":"M Yoneda","year":"2022","unstructured":"Yoneda M, Kobayashi T, Asako N, Iwaki M, Saito S, Nakajima A. Pan-peroxisome proliferator-activated receptor agonist lanifibranor as a dominant candidate pharmacological therapy for nonalcoholic fatty liver disease. Hepatobiliary Surg Nutr. 2022;11(3):433\u20135.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"7","key":"1945_CR146","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/ph17070875","volume":"17","author":"M Rao","year":"2024","unstructured":"Rao M, McDuffie E, Srivastava S, Plaisted W, Sachs C. Safety implications of modulating nuclear receptors: a comprehensive analysis from non-clinical and clinical perspectives. Pharmaceuticals. 2024;17(7):875.","journal-title":"Pharmaceuticals"},{"key":"1945_CR147","doi-asserted-by":"publisher","first-page":"100357","DOI":"10.1016\/j.aohep.2021.100357","volume":"24","author":"D Cabrera","year":"2021","unstructured":"Cabrera D, Rao I, Raasch F, Solis N, Pizarro M, Freire M, et al. Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice. Ann Hepatol. 2021;24:100357.","journal-title":"Ann Hepatol"},{"issue":"9","key":"1945_CR148","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1111\/liv.12794","volume":"35","author":"M Pizarro","year":"2015","unstructured":"Pizarro M, Sol\u00eds N, Quintero P, Barrera F, Cabrera D, Rojas-de Santiago P, et al. Beneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis. Liver Int. 2015;35(9):2129\u201338.","journal-title":"Liver Int"},{"issue":"13","key":"1945_CR149","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1111\/bph.15784","volume":"179","author":"B Schreier","year":"2022","unstructured":"Schreier B, Zipprich A, Uhlenhaut H, Gekle M. Mineralocorticoid receptors in non-alcoholic fatty liver disease. Br J Pharmacol. 2022;179(13):3165\u201377.","journal-title":"Br J Pharmacol"},{"issue":"8","key":"1945_CR150","doi-asserted-by":"publisher","first-page":"3745","DOI":"10.1096\/fj.13-245415","volume":"28","author":"A Armani","year":"2014","unstructured":"Armani A, Cinti F, Marzolla V, Morgan J, Cranston GA, Antelmi A, et al. Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice. Faseb J. 2014;28(8):3745\u201357.","journal-title":"Faseb J"},{"issue":"2","key":"1945_CR151","doi-asserted-by":"publisher","first-page":"bqz010","DOI":"10.1210\/endocr\/bqz010","volume":"161","author":"D Ferguson","year":"2020","unstructured":"Ferguson D, Hutson I, Tycksen E, Pietka TA, Bauerle K, Harris CA. Role of mineralocorticoid receptor in adipogenesis and obesity in male mice. Endocrinology. 2020;161(2):bqz010.","journal-title":"Endocrinology"},{"issue":"1","key":"1945_CR152","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.1152\/ajpendo.00258.2007","volume":"295","author":"G Lastra","year":"2008","unstructured":"Lastra G, Whaley-Connell A, Manrique C, Habibi J, Gutweiler AA, Appesh L, et al. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Am J Physiol Endocrinol Metab. 2008;295(1):E110\u20136.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"1945_CR153","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1210\/en.2009-0869","volume":"151","author":"T Wada","year":"2010","unstructured":"Wada T, Kenmochi H, Miyashita Y, Sasaki M, Ojima M, Sasahara M, et al. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet. Endocrinology. 2010;151(5):2040\u20139.","journal-title":"Endocrinology"},{"issue":"12","key":"1945_CR154","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1111\/dom.12989","volume":"19","author":"SA Polyzos","year":"2017","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS, Polymerou V, Katsinelos P. Effects of combined low-dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non-invasive indices of steatosis and fibrosis, and adipokine levels in non-alcoholic fatty liver disease: a randomized controlled trial. Diabetes Obes Metab. 2017;19(12):1805\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"1945_CR155","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1124\/dmd.121.000483","volume":"50","author":"S Stern","year":"2022","unstructured":"Stern S, Kurian R, Wang H. Clinical relevance of the constitutive androstane receptor. Drug Metab Dispos. 2022;50(7):1010\u20138.","journal-title":"Drug Metab Dispos"},{"issue":"38","key":"1945_CR156","doi-asserted-by":"publisher","first-page":"25984","DOI":"10.1074\/jbc.M109.016808","volume":"284","author":"J Gao","year":"2009","unstructured":"Gao J, He J, Zhai Y, Wada T, Xie W. The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem. 2009;284(38):25984\u201392.","journal-title":"J Biol Chem"},{"issue":"1","key":"1945_CR157","doi-asserted-by":"publisher","first-page":"20169","DOI":"10.1038\/s41598-019-56570-0","volume":"9","author":"C Lukowicz","year":"2019","unstructured":"Lukowicz C, Ellero-Simatos S, R\u00e9gnier M, Oliviero F, Lasserre F, Polizzi A, et al. Dimorphic metabolic and endocrine disorders in mice lacking the constitutive androstane receptor. Sci Rep. 2019;9(1):20169.","journal-title":"Sci Rep"},{"issue":"4","key":"1945_CR158","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1021\/acs.jmedchem.2c01140","volume":"66","author":"I Mejdrov\u00e1","year":"2023","unstructured":"Mejdrov\u00e1 I, Du\u0161ek J, \u0160kach K, Stefela A, Skoda J, Chalupsk\u00fd K, et al. Discovery of novel human constitutive androstane receptor agonists with the imidazo[1,2-a]pyridine structure. J Med Chem. 2023;66(4):2422\u201356.","journal-title":"J Med Chem"},{"issue":"1","key":"1945_CR159","doi-asserted-by":"publisher","first-page":"100930","DOI":"10.1016\/j.jhepr.2023.100930","volume":"6","author":"M Huillet","year":"2024","unstructured":"Huillet M, Lasserre F, Gratacap M-P, Engelmann B, Bruse J, Polizzi A, et al. Pharmacological activation of constitutive androstane receptor induces female-specific modulation of hepatic metabolism. JHEP Rep. 2024;6(1):100930.","journal-title":"JHEP Rep"},{"issue":"2","key":"1945_CR160","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2174\/187569209788654005","volume":"7","author":"JP Hernandez","year":"2009","unstructured":"Hernandez JP, Mota LC, Baldwin WS. Activation of CAR and PXR by dietary, environmental and occupational chemicals alters drug metabolism, intermediary metabolism, and cell proliferation. Curr Pharmacogenom Person Med. 2009;7(2):81\u2013105.","journal-title":"Curr Pharmacogenom Person Med"},{"key":"1945_CR161","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.isci.2018.10.018","volume":"9","author":"J Tian","year":"2018","unstructured":"Tian J, Marino R, Johnson C, Locker J. Binding of drug-activated CAR\/Nr1i3 alters metabolic regulation in the liver. iScience. 2018;9:209\u201328.","journal-title":"iScience"},{"issue":"22","key":"1945_CR162","doi-asserted-by":"publisher","first-page":"13768","DOI":"10.3390\/ijms232213768","volume":"23","author":"EJ Montgomery","year":"2022","unstructured":"Montgomery EJ, Xing E, Campbell MJ, Li P-K, Blachly JS, Tsung A, et al. Constitutively active androgen receptor in hepatocellular carcinoma. Int J Mol Sci. 2022;23(22):13768.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1945_CR163","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/toxsci\/kfae057","volume":"200","author":"R Sonkar","year":"2024","unstructured":"Sonkar R, Ma H, Waxman DJ. Steatotic liver disease induced by TCPOBOP-activated hepatic constitutive androstane receptor: primary and secondary gene responses with links to disease progression. Toxicol Sci. 2024;200(2):324\u201345.","journal-title":"Toxicol Sci"},{"issue":"3","key":"1945_CR164","first-page":"382","volume":"14","author":"DJ Heard","year":"2000","unstructured":"Heard DJ, Norby PL, Holloway J, Vissing H. Human ERRgamma, a third member of the estrogen receptor-related receptor (ERR) subfamily of orphan nuclear receptors: tissue-specific isoforms are expressed during development and in the adult. Mol Endocrinol. 2000;14(3):382\u201392.","journal-title":"Mol Endocrinol"},{"issue":"26","key":"1945_CR165","doi-asserted-by":"publisher","first-page":"21628","DOI":"10.1074\/jbc.M111.315168","volume":"287","author":"DK Kim","year":"2012","unstructured":"Kim DK, Ryu D, Koh M, Lee MW, Lim D, Kim MJ, et al. Orphan nuclear receptor estrogen-related receptor \u03b3 (ERR\u03b3) is key regulator of hepatic gluconeogenesis. J Biol Chem. 2012;287(26):21628\u201339.","journal-title":"J Biol Chem"},{"issue":"1","key":"1945_CR166","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmet.2007.06.007","volume":"6","author":"WA Alaynick","year":"2007","unstructured":"Alaynick WA, Kondo RP, Xie W, He W, Dufour CR, Downes M, et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab. 2007;6(1):13\u201324.","journal-title":"Cell Metab"},{"issue":"1","key":"1945_CR167","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/aps.2014.121","volume":"36","author":"\u00c9 Audet-Walsh","year":"2015","unstructured":"Audet-Walsh \u00c9, Gigu\u00e9re V. The multiple universes of estrogen-related receptor \u03b1 and \u03b3 in metabolic control and related diseases. Acta Pharmacol Sin. 2015;36(1):51\u201361.","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"1945_CR168","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cmet.2007.03.007","volume":"5","author":"CR Dufour","year":"2007","unstructured":"Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, et al. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab. 2007;5(5):345\u201356.","journal-title":"Cell Metab"},{"issue":"1","key":"1945_CR169","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41531-022-00369-w","volume":"8","author":"SN Fox","year":"2022","unstructured":"Fox SN, McMeekin LJ, Savage CH, Joyce KL, Boas SM, Simmons MS, et al. Estrogen-related receptor gamma regulates mitochondrial and synaptic genes and modulates vulnerability to synucleinopathy. NPJ Parkinson\u2019s Dis. 2022;8(1):106.","journal-title":"NPJ Parkinson's Dis"},{"issue":"7","key":"1945_CR170","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1128\/MCB.01156-14","volume":"35","author":"T Wang","year":"2015","unstructured":"Wang T, McDonald C, Petrenko NB, Leblanc M, Wang T, Giguere V, et al. Estrogen-related receptor \u03b1 (ERR\u03b1) and ERR\u03b3 are essential coordinators of cardiac metabolism and function. Mol Cell Biol. 2015;35(7):1281\u201398.","journal-title":"Mol Cell Biol"},{"issue":"12","key":"1945_CR171","first-page":"158521","volume":"1864","author":"DK Kim","year":"2019","unstructured":"Kim DK, Kim YH, Lee JH, Jung YS, Kim J, Feng R, Jeon TI, Lee IK, Cho SJ, Im SS, Dooley S. Estrogen-related receptor \u03b3 controls sterol regulatory element-binding protein-1c expression and alcoholic fatty liver. Biochim Biophys Acta (BBA) Mol Cell Biol Lipids. 2019;1864(12):158521.","journal-title":"Biochim Biophys Acta (BBA) Mol Cell Biol Lipids"},{"issue":"9","key":"1945_CR172","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.2337\/db12-0946","volume":"62","author":"DK Kim","year":"2013","unstructured":"Kim DK, Gang GT, Ryu D, Koh M, Kim YN, Kim SS, et al. Inverse agonist of nuclear receptor ERR\u03b3 mediates antidiabetic effect through inhibition of hepatic gluconeogenesis. Diabetes. 2013;62(9):3093\u2013102.","journal-title":"Diabetes"},{"issue":"44","key":"1945_CR173","doi-asserted-by":"publisher","first-page":"38035","DOI":"10.1074\/jbc.M111.250613","volume":"286","author":"DK Kim","year":"2011","unstructured":"Kim DK, Kim JR, Koh M, Kim YD, Lee JM, Chanda D, et al. Estrogen-related receptor \u03b3 (ERR\u03b3) is a novel transcriptional regulator of phosphatidic acid phosphatase, LIPIN1, and inhibits hepatic insulin signaling. J Biol Chem. 2011;286(44):38035\u201342.","journal-title":"J Biol Chem"},{"key":"1945_CR174","doi-asserted-by":"publisher","first-page":"1434024","DOI":"10.3389\/fphar.2024.1434024","volume":"15","author":"Q Liu","year":"2024","unstructured":"Liu Q, Li X, Luo Y. Tanshinone IIA delays liver aging by modulating oxidative stress. Front Pharmacol. 2024;15:1434024.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1945_CR175","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nm.3483","volume":"20","author":"D-K Kim","year":"2014","unstructured":"Kim D-K, Jeong J-H, Lee J-M, Kim KS, Park S-H, Kim YD, et al. Inverse agonist of estrogen-related receptor \u03b3 controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014;20(4):419\u201324.","journal-title":"Nat Med"},{"issue":"11","key":"1945_CR176","doi-asserted-by":"publisher","first-page":"547","DOI":"10.5483\/BMBRep.2022.55.11.089","volume":"55","author":"DH Kim","year":"2022","unstructured":"Kim DH, Kim MJ, Kim NY, Lee S, Byun JK, Yun JW, et al. DN200434, an orally available inverse agonist of estrogen-related receptor \u03b3, induces ferroptosis in sorafenib-resistant hepatocellular carcinoma. BMB Rep. 2022;55(11):547\u201352.","journal-title":"BMB Rep"},{"key":"1945_CR177","doi-asserted-by":"crossref","unstructured":"Peleman C, Francque S, Berghe TV. Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation. eBioMedicine. 2024;102.","DOI":"10.1016\/j.ebiom.2024.105088"},{"issue":"9","key":"1945_CR178","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41418-024-01348-9","volume":"31","author":"C Peleman","year":"2024","unstructured":"Peleman C, Hellemans S, Veeckmans G, Arras W, Zheng H, Koeken I, et al. Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver disease. Cell Death Differ. 2024;31(9):1113\u201326.","journal-title":"Cell Death Differ"},{"key":"1945_CR179","doi-asserted-by":"publisher","first-page":"113374","DOI":"10.1016\/j.biopha.2022.113374","volume":"153","author":"S Wang","year":"2022","unstructured":"Wang S, Liu Z, Geng J, Li L, Feng X. An overview of ferroptosis in non-alcoholic fatty liver disease. Biomed Pharmacother. 2022;153:113374.","journal-title":"Biomed Pharmacother"},{"key":"1945_CR180","doi-asserted-by":"publisher","first-page":"1283170","DOI":"10.3389\/fmmed.2023.1283170","volume":"3","author":"C Theys","year":"2023","unstructured":"Theys C, Vanderhaeghen T, Van Dijck E, Peleman C, Scheepers A, Ibrahim J, et al. Loss of PPAR\u03b1 function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated steatotic liver disease (MASLD). Front Mol Med. 2023;3:1283170.","journal-title":"Front Mol Med"},{"key":"1945_CR181","doi-asserted-by":"publisher","first-page":"1250719","DOI":"10.3389\/fimmu.2023.1250719","volume":"14","author":"S Horiuchi","year":"2023","unstructured":"Horiuchi S, Koike T, Takebuchi H, Hoshino K, Sasaki I, Fukuda-Ohta Y, et al. SpiB regulates the expression of B-cell-related genes and increases the longevity of memory B cells. Front Immunol. 2023;14:1250719.","journal-title":"Front Immunol"},{"issue":"8","key":"1945_CR182","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/ni.2352","volume":"13","author":"T Kanaya","year":"2012","unstructured":"Kanaya T, Hase K, Takahashi D, Fukuda S, Hoshino K, Sasaki I, et al. The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells. Nat Immunol. 2012;13(8):729\u201336.","journal-title":"Nat Immunol"},{"issue":"16","key":"1945_CR183","doi-asserted-by":"publisher","first-page":"12918","DOI":"10.18632\/oncotarget.24161","volume":"9","author":"YK Shang","year":"2018","unstructured":"Shang YK, Li C, Liu ZK, Kong LM, Wei D, Xu J, et al. System analysis of the regulation of the immune response by CD147 and FOXC1 in cancer cell lines. Oncotarget. 2018;9(16):12918\u201331.","journal-title":"Oncotarget"},{"issue":"1","key":"1945_CR184","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-018-04567-0","volume":"9","author":"Y Le","year":"2018","unstructured":"Le Y, Gao H, Bleday R, Zhu Z. The homeobox protein VentX reverts immune suppression in the tumor microenvironment. Nat Commun. 2018;9(1):2175.","journal-title":"Nat Commun"},{"issue":"1","key":"1945_CR185","doi-asserted-by":"publisher","first-page":"108731","DOI":"10.1016\/j.isci.2023.108731","volume":"27","author":"Y Le","year":"2024","unstructured":"Le Y, Gao H, Le J, Hornick JL, Bleday R, Wee J, et al. VentX promotes tumor specific immunity and efficacy of immune checkpoint inhibitors. iScience. 2024;27(1):108731.","journal-title":"iScience"},{"issue":"7","key":"1945_CR186","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1172\/JCI45556","volume":"121","author":"X Wu","year":"2011","unstructured":"Wu X, Gao H, Ke W, Giese RW, Zhu Z. The homeobox transcription factor VentX controls human macrophage terminal differentiation and proinflammatory activation. J Clin Invest. 2011;121(7):2599\u2013613.","journal-title":"J Clin Invest"},{"issue":"2","key":"1945_CR187","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.cmet.2017.07.004","volume":"26","author":"A Abdul-Wahed","year":"2017","unstructured":"Abdul-Wahed A, Guilmeau S, Postic C. Sweet sixteenth for ChREBP: established roles and future goals. Cell Metab. 2017;26(2):324\u201341.","journal-title":"Cell Metab"},{"key":"1945_CR188","doi-asserted-by":"publisher","first-page":"276850","DOI":"10.1155\/2015\/276850","volume":"2015","author":"T Liu","year":"2015","unstructured":"Liu T, Zhou Y, Ko KS, Yang H. Interactions between Myc and mediators of inflammation in chronic liver diseases. Med Inflamm. 2015;2015:276850.","journal-title":"Med Inflamm"},{"key":"1945_CR189","doi-asserted-by":"publisher","first-page":"154569","DOI":"10.1016\/j.cyto.2018.10.010","volume":"124","author":"D Kaltenecker","year":"2019","unstructured":"Kaltenecker D, Themanns M, Mueller KM, Spirk K, Suske T, Merkel O, et al. Hepatic growth hormone\u2014JAK2\u2014STAT5 signalling: metabolic function, non-alcoholic fatty liver disease and hepatocellular carcinoma progression. Cytokine. 2019;124:154569.","journal-title":"Cytokine"},{"key":"1945_CR190","doi-asserted-by":"publisher","first-page":"1165306","DOI":"10.3389\/fimmu.2023.1165306","volume":"14","author":"J Nagenborg","year":"2023","unstructured":"Nagenborg J, Jin H, Ruder AV, Temmerman L, Mees B, Schalkwijk C, et al. GM-CSF-activated STAT5A regulates macrophage functions and inflammation in atherosclerosis. Front Immunol. 2023;14:1165306.","journal-title":"Front Immunol"},{"key":"1945_CR191","doi-asserted-by":"publisher","first-page":"155392","DOI":"10.1016\/j.cyto.2020.155392","volume":"139","author":"M Surbek","year":"2021","unstructured":"Surbek M, Tse W, Moriggl R, Han X. A centric view of JAK\/STAT5 in intestinal homeostasis, infection, and inflammation. Cytokine. 2021;139:155392.","journal-title":"Cytokine"},{"issue":"1","key":"1945_CR192","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cgh.2023.07.013","volume":"22","author":"SM Francque","year":"2024","unstructured":"Francque SM, Noureddin M, Krag A. Learnings from the graveyard of phase 2 and 3 nonalcoholic steatohepatitis trials. Clin Gastroenterol Hepatol. 2024;22(1):16\u20139.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"1945_CR193","first-page":"378","volume":"36","author":"E Koureta","year":"2023","unstructured":"Koureta E, Cholongitas E. Combination therapies in nonalcoholic fatty liver disease using antidiabetic and disease-specific drugs. Ann Gastroenterol. 2023;36(4):378\u201391.","journal-title":"Ann Gastroenterol"},{"issue":"5","key":"1945_CR194","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jhep.2022.12.025","volume":"78","author":"V Ratziu","year":"2023","unstructured":"Ratziu V, Charlton M. Rational combination therapy for NASH: insights from clinical trials and error. J Hepatol. 2023;78(5):1073\u20139.","journal-title":"J Hepatol"},{"issue":"3","key":"1945_CR195","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41594-023-01195-1","volume":"31","author":"A Chervova","year":"2024","unstructured":"Chervova A, Molliex A, Baymaz HI, Coux R-X, Papadopoulou T, Mueller F, et al. Mitotic bookmarking redundancy by nuclear receptors in pluripotent cells. Nat Struct Mol Biol. 2024;31(3):513\u201322.","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"1945_CR196","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1210\/mend.16.3.0814","volume":"16","author":"JM Hall","year":"2002","unstructured":"Hall JM, McDonnell DP, Korach KS. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol. 2002;16(3):469\u201386.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"1945_CR197","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.jhep.2023.03.038","volume":"79","author":"F Tacke","year":"2023","unstructured":"Tacke F, Puengel T, Loomba R, Friedman SL. An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH. J Hepatol. 2023;79(2):552\u201366.","journal-title":"J Hepatol"},{"key":"1945_CR198","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fgene.2019.00435","volume":"10","author":"AP Gureev","year":"2019","unstructured":"Gureev AP, Shaforostova EA, Popov VN. Regulation of mitochondrial biogenesis as a way for active longevity: interaction between the Nrf2 and PGC-1\u03b1 signaling pathways. Front Genet. 2019;10:435.","journal-title":"Front Genet"},{"issue":"43","key":"1945_CR199","doi-asserted-by":"publisher","first-page":"40265","DOI":"10.1074\/jbc.M206324200","volume":"277","author":"JM Huss","year":"2002","unstructured":"Huss JM, Kopp RP, Kelly DP. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and \u2013gamma. identification of novel leucine-rich interaction motif within PGC-1alpha. J Biol Chem. 2002;277(43):40265\u201374.","journal-title":"J Biol Chem"},{"issue":"6","key":"1945_CR200","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0092-8674(00)81410-5","volume":"92","author":"P Puigserver","year":"1998","unstructured":"Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 1998;92(6):829\u201339.","journal-title":"Cell"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-025-01945-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-025-01945-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:29:41Z","timestamp":1757341781000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalepigeneticsjournal.biomedcentral.com\/articles\/10.1186\/s13148-025-01945-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1945"],"URL":"https:\/\/doi.org\/10.1186\/s13148-025-01945-6","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"assertion":[{"value":"8 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Antwerp University Hospital (references A04-21 and 6\/25\/125, Belgian registration number B30020071389, date of approval: 21 October 2019). Informed consent was obtained for all involved patients. Approvals for the SteatoSITE database were provided by the West of Scotland Research Ethics Committee 4 (Reference: 20\/WS\/0002; 18 February 2020), Public Benefit and Privacy Panel for Health and Social Care (PBPP; Reference: 1819-0091; 4 June 2021), Institutional Research & Development departments and Caldicott Guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"138"}}